If tirzepatide is stopped, appetite may increase and weight regain can occur
Genetic variants in pathways including the FTO gene (rs9939609) and MC4R gene (rs17782313) influence appetite regulation set-point and metabolic response, meaning two patients on identical doses may experience different trajectories
Factors like diet, exercise, oxidative stress, and aging can affect your natural glutathione levels
Conversely, if your genetics suggest reduced GLP-1 sensitivity, your provider can proactively plan for dose increases earlier in your treatment timeline, optimizing your weight loss trajectory from the start
Mostertz, J., Scharf, C., Hecker, M., and Homuth, G., Microbiology , 2004, vol
Food and Drug Administration has approved GLP-1 medications for the treatment of these two chronic diseases